{"transactions":[{"id":740194,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38839,"kind":"person","name":"Kaplan Matthew L.","position":1,"cik":"0001895952","reported_name":"Kaplan Matthew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T16:10:16.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 35,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Kaplan's continued service on the Company's Board of Directors on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock."}],"balance_after":159760,"source":{"system":"sec-edgar","filing":"0001104659-26-073455","document":"tm2617536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895952/000110465926073455/tm2617536-1_4seq1.xml","form_type":"4"}},{"id":1005938,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38839,"kind":"person","name":"Kaplan Matthew L.","position":1,"cik":"0001895952","reported_name":"Kaplan Matthew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T08:00:15.000Z","date":"2025-11-05","kind":"purchase","planned":false,"acquired":true,"shares":11000,"price":5.84,"value":64240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $5.81 to $5.88. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":124760,"source":{"system":"sec-edgar","filing":"0001104659-25-107418","document":"tm2530379-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895952/000110465925107418/tm2530379-1_4seq1.xml","form_type":"4"}},{"id":1113733,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38839,"kind":"person","name":"Kaplan Matthew L.","position":1,"cik":"0001895952","reported_name":"Kaplan Matthew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T16:31:16.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Kaplan's continued service on the Company's Board of Directors on such dates."}],"balance_after":113760,"source":{"system":"sec-edgar","filing":"0001104659-25-058919","document":"tm2517867-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895952/000110465925058919/tm2517867-3_4seq1.xml","form_type":"4"}},{"id":1480949,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38839,"kind":"person","name":"Kaplan Matthew L.","position":1,"cik":"0001895952","reported_name":"Kaplan Matthew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T16:22:55.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Kaplan's continued service on the board on such dates."}],"balance_after":83760,"source":{"system":"sec-edgar","filing":"0001104659-24-071289","document":"tm2416958-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895952/000110465924071289/tm2416958-3_4seq1.xml","form_type":"4"}},{"id":1850038,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38839,"kind":"person","name":"Kaplan Matthew L.","position":1,"cik":"0001895952","reported_name":"Kaplan Matthew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T08:16:06.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 18,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Kaplan's continued service on the board on such dates."}],"balance_after":53760,"source":{"system":"sec-edgar","filing":"0001104659-23-072606","document":"tm2319007-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895952/000110465923072606/tm2319007-2_4seq1.xml","form_type":"4"}},{"id":2270641,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38839,"kind":"person","name":"Kaplan Matthew L.","position":1,"cik":"0001895952","reported_name":"Kaplan Matthew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T08:32:28.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":1823,"price":17.47,"value":31847.81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $17.33 to $17.50. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":35760,"source":{"system":"sec-edgar","filing":"0001104659-22-060910","document":"tm2215423d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895952/000110465922060910/tm2215423d2_4.xml","form_type":"4"}},{"id":2270640,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38839,"kind":"person","name":"Kaplan Matthew L.","position":1,"cik":"0001895952","reported_name":"Kaplan Matthew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T08:32:28.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":1177,"price":15.96,"value":18784.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $15.75 to $16.00. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":33937,"source":{"system":"sec-edgar","filing":"0001104659-22-060910","document":"tm2215423d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895952/000110465922060910/tm2215423d2_4.xml","form_type":"4"}},{"id":2305085,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38839,"kind":"person","name":"Kaplan Matthew L.","position":1,"cik":"0001895952","reported_name":"Kaplan Matthew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-04-05T16:48:40.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025."}],"balance_after":15000,"derivative":{"exercise_price":7.02,"exercise_date":"2023-04-01","expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-042821","document":"tm2211420-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895952/000110465922042821/tm2211420-6_4seq1.xml","form_type":"4"}}]}